ORGANIC
LETTERS
2006
Vol. 8, No. 4
565-568
Development of a Novel, Highly Efficient
Halide-Catalyzed Sulfenylation of Indoles
Matthew Tudge,* Minoru Tamiya, Cecile Savarin, and Guy R. Humphrey
Department of Process Research, Merck Research Laboratories, P.O. Box 2000,
Rahway, New Jersey 07065
Received October 28, 2005
ABSTRACT
The reaction of a variety of indoles with N-thioalkyl- and N-thioarylphthalimides to produce 3-thioindoles is reported. Catalytic quantities of
halide-containing salts are crucial to the success of this reaction. This highly efficient reaction provides sulfenylated indoles from bench-
stable, readily available starting materials in good to excellent yields.
Sulfenylated indole motifs are ubiquitous in many biologi-
cally important compounds.1a-d In particular, the therapeutic
value of numerous 3-thioindoles has been assessed in several
disease areas, including obesity,1a cancer,1b heart disease,1c
and bacterial infection.1d Preparation of such compounds is
generally achieved by electrophilic aromatic sulfenylation
chemistry. Sulfenylating agents such as disulfides,2a sulfenyl
halides,3b and quinone mono-O,S-acetals4c have all been
employed in this reaction, but are often impractical on both
small and large scale due to the accessibility, substrate
compatibility, and stability of these reagents. To overcome
these problems, sulfenylations utilizing thiols activated in
situ by N-chlorosuccinimide5 or transition-metal catalysts6
have been developed.
In the context of an ongoing drug discovery program, we
required an efficient sulfenylation method that could be
carried out on a range of electronically distinct indoles, using
bench-stable sulfenylating agents at relatively high concen-
tration (Scheme 1).7
Scheme 1
(1) (a) Acton, J. L.; Meinke, P. T.; Wood, H.; Black, R. M. PCT Int.
Appl. WO 2004/019869 A2, 2004. (b) (i) Avis, I.; Mart´ınez, A.; Tauler, J.;
Zudaire, E.; Mayburd, A.; Abu-Ghazaleh, R.; Ondrey, F.; Mulshine, J. L.
Cancer Res. 2005, 65, 4181. (ii) De Martino, G.; La Regina, G.; Coluccia,
A.; Edler, M. C.; Barbera, M. C.; Brancale, A.; Wilcox, E.; Hamel, E.;
Artico, M.; Silvestri, R. J. Med. Chem. 2004, 47, 6120. (c) Funk, C. D.
Nat. ReV. Drug DiscoVery 2005, 4, 664. (d) Khandekar, S. S.; Gentry, D.
R.; Van Aller, G. S.; Doyle, M. L.; Chambers, P. A.; Konstantinidis, A.
K.; Brandt, M.; Daines, R. A.; Lonsdale, J. T. J. Biol. Chem. 2001, 276,
30024.
(2) (a) Atkinson, J. G.; Hamel, P.; Girard, Y. Synthesis 1988, 480. (b)
(i) Scoffone, E.; Fontana, A.; Rocchi, R. Biochemistry 1968, 7, 971. (ii)
Anzai, K. J. Heterocycl. Chem. 1979, 16, 567. (c) Matsugi, M.; Murata,
K.; Gotanda, K.; Nambu, H.; Anilkumar, G.; Matsumoto, K.; Kita, Y. J.
Org. Chem. 2001, 66, 2434.
To date, however, no general sulfenylation protocol has
been reported that is economical with respect to the sulfur
component,8 avoids the use of harsh chlorination conditions,6
(5) For sulfenylations utilising and/or liberating >1 equiv of sulfide, see
refs 3 and 4.
(3) Schlosser, K. M.; Krasutsky, A. P.; Hamilton, H. W.; Reed, J. E.;
Sexton, K. Org. Lett. 2004, 6, 819.
(4) Maeda, Y.; Koyabu, M.; Nishimura, T.; Uemura, S. J. Org. Chem.
2004, 69, 7688.
(6) In our hands, sulfenylations involving the use of SO2Cl2 (ref 2b, ii)
or NCS (ref 3) gave significant quantities of 3-chloroindole byproducts.
(7) Trost, B. M. Chem. ReV. 1978, 78, 363.
(8) Kuehen, M. E. J. Org. Chem. 1963, 28, 2124.
10.1021/ol052615c CCC: $33.50
© 2006 American Chemical Society
Published on Web 01/19/2006